Biogen Idec buys neurodegenerative disease rights
December 21, 2010Research and Development Alzheimer's, Alzheimer's disease, Alzheimer’s, Alzheimer’s disease, Biogen, Biogen IDEC, Neurimmune, Parkinson's disease, Parkinson’s disease, amyotrophic lateral sclerosis, neurodegenerative diseases
Biogen Idec has acquired a subsidiary of Swiss biotech company Neurimmune, and the rights to three pre-clinical immunotherapy drugs. The …
Congressman says FDA should scrutinise J&J’s manufacturing partners
December 21, 2010Manufacturing and Production BestSweet, FDA, J&J, JJ, Johnson & Johnson, McNeil, Rolaids, manufacturing compliance, recalls
The latest flurry of recalls from Johnson & Johnson has prompted additional calls for a wide-ranging investigation of the company’s …
Scottish First Minister seeks talks with Aptuit over plant closures
December 21, 2010Manufacturing and Production Aptuit, Scotland, manufacturing facilities, pharma manufacturing
US contract manufacturing and drug development company Aptuit says it may shut down two facilities in Lothian, Scotland, because demand …
CRM and software-as-a-service
December 21, 2010Sales and Marketing CRM, Dan Goldsmith, Service Insight, Veeva Systems
Service Insight from Dan Goldsmith, general manager, Europe, Veeva SystemsCriminal mastermind, Frank Abagnale Jr. (1901-1980), successfully conned millions of dollars …
Contract research news in brief
December 20, 2010Research and Development Biomodels, CIT, Charles River Laboratories, Dedicated Phase I, INC Research, PPD
Our round-up of recent development in the contract research sector includes updates from Charles River, CIT/Biomodels, INC Research, PPD and …
FDA delays approval of AstraZeneca’s Brilinta
December 20, 2010Research and Development, Sales and Marketing AZ, AstraZeneca, Brilinta, Brilique, acute coronary syndrome
US regulators have delayed approving AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor) because their want more information about a crucial clinical trial. …
Italy OKs first large-scale unit for making radiolabelled peptides
December 20, 2010Manufacturing and Production AIFA, Advanced Accelerator Applications, BioSynthema, Italy
The world’s first industrial-scale manufacturing facility for radiolabelled peptides used in nuclear medicine has been approved by the Italian Pharmaceutical …
Sanofi signs new oncology research deals
December 20, 2010Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs
Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …
Aesica aims to double capacity and turnover with UCB plants
December 20, 2010Manufacturing and Production Aesica, UCB, pharma manufacturing
UK contract manufacturer and ingredient supplier Aesica Pharmaceuticals is planning to double its production capacity with the acquisition of three …
CME Spotlight: Uniting European CME
December 20, 2010Medical Communications CME, Continuing medical education, Eugene Pozniak
I started writing this month’s column while still in Berlin, one of my favourite cities in Europe, and also the …
Refreshed Wellbeing appoints new creative director
December 17, 2010Medical Communications George Teague, Refreshed Wellbeing, appointment, medical communications
Reigate, UK-based healthcare comms agency Refreshed Wellbeing has appointed George Teague as creative director. His appointment comes at a time …
Sanofi and Merck Serono to collaborate in oncology
December 17, 2010Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis
Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …
Pharma careers options – management in China
December 17, 2010Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment
Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …
New hepatitis C drug offers cure for more patients
December 17, 2010Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir
A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …
Chime launches new healthcare comms venture
December 17, 2010Medical Communications Chime Communications, David Rowley, Sandy Royden, healthcare comms agency, medical communications
Communications giant Chime is putting money into a new healthcare PR venture which will be run by the ex-global head …
Government consults on UK value-based pricing
December 17, 2010Sales and Marketing ABPI, Drug pricing, pharma pricing, value-based pricing
The government has begun a consolutation process for its plans to change the way medicines are priced in the UK. …
Merck KGaA appoints new head of pharma
December 17, 2010Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing
Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
Government pushes on with major NHS reforms
December 16, 2010GP consortia, Health and Wellbeing Boards, NHS, NHS Commissioning Board, NHS Operating Framework, NHS reforms, PCTs
The government has set out a roadmap for its wide-ranging NHS reform plans that promises no let up in the …
Reforms are a ‘risky business’ for the NHS
December 16, 2010Civitas, GP commissioning, NHS, NHS reforms, PCTs
The government is taking a ‘big risk’ with NHS reforms that will hand GPs responsibility for commissioning services, according to …
Novo rebuked after diabetes promotion breaches Code
December 16, 2010Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly
Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
